Company
MERCK Kommanditgesellschaft auf Aktien
Headquarters: Darmstadt, Germany
Employees: 60,334
CEO: Ms. Belen Garijo Lopez M.D.
Market Cap
€62.63 Billion
EUR as of Jan. 1, 2025
US$65.17 Billion
MERCK Kommanditgesellschaft auf Aktien Categories
Germany Healthcare Drug Manufacturers—Specialty & GenericGermany Healthcare Germany Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $75.33 B |
| Haleon plc | $42.16 B |
| Takeda Pharmaceutical Company Limited | $41.47 B |
| Teva Pharmaceutical Industries Limited | $18.95 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | €20.87 B |
| EBITDA | €5.68 B |
| Gross Profit TTM | €12.19 B |
| Profit Margin | 12.58% |
| Operating Margin | 14.82% |
| Quarterly Revenue Growth | 0.90% |
Stocks & Indices
MERCK Kommanditgesellschaft auf Aktien has the following listings and related stock indices.
Stock: FSX: MRK wb_incandescent
Stock: XETR: MRK wb_incandescent
Stock: XSTU: MRKC wb_incandescent
Stock: MTA: MRK wb_incandescent